Mallinckrodt plc MNK was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $260.28 to $65.28 since Apr 10.
The company has seen one positive revision in the past 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Mallinckrodt. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
Mallinckrodt currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is positive.
Some other stocks worth consideration in the generic drugs industry include Actavis plc ACT, Teva Pharmaceutical Industries Limited TEVA and Impax Laboratories Inc. IPXL. While Actavis sports a Zacks Rank #1, Teva Pharmaceutical Industries and Impax Laboratories have a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ACTAVIS PLC ACT: Free Stock Analysis Report
IMPAX LABORATRS IPXL: Free Stock Analysis Report
MALLINCKRODT PL MNK: Free Stock Analysis Report
TEVA PHARM ADR TEVA: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsThe company has seen one positive revision in the past 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Mallinckrodt. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
Mallinckrodt currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is positive.
Some other stocks worth consideration in the generic drugs industry include Actavis plc ACT, Teva Pharmaceutical Industries Limited TEVA and Impax Laboratories Inc. IPXL. While Actavis sports a Zacks Rank #1, Teva Pharmaceutical Industries and Impax Laboratories have a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ACTAVIS PLC ACT: Free Stock Analysis Report
IMPAX LABORATRS IPXL: Free Stock Analysis Report
MALLINCKRODT PL MNK: Free Stock Analysis Report
TEVA PHARM ADR TEVA: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
